DOI QR코드

DOI QR Code

Overexpression of Hypermethylated Homeobox A11 (HOXA11) Inhibits Tumor Cell Growth and Induces Apoptosis in Cervical Cancer

  • Received : 2024.02.21
  • Accepted : 2024.05.16
  • Published : 2024.06.30

Abstract

This study aimed to elucidate the potential of Homeobox A11 (HOXA11) as a therapeutic target and a diagnostic methylation marker for cervical cancer. Gene expression analysis using cDNA microarray in cervical cancer cell lines revealed significantly reduced expression of the HOXA11 gene. Subsequent investigation of HOXA11 promoter methylation in samples from normal individuals and invasive cervical cancer patients showed over 53.2% higher methylation in cancer scrapes compared to normal scrapes. Furthermore, overexpression of HOXA11, which is downregulated in cervical cancer, strongly suppressed cell growth in cervical cancer cell lines, HeLa and HT3. Additionally, we performed transferase dUTP nick end labeling assay and confirmed that the inhibition of cervical cancer cell proliferation occurred via apoptosis. Mechanistically, overexpression of HOXA11 led to mitochondrial apoptosis characterized by PARP cleavage due to increased c-Myc and enhanced cytochrome C secretion into the cytoplasm. These findings suggest that HOXA11 could potentially serve as a methylation marker for diagnosing cervical cancer and as a novel therapeutic target for its treatment.

Keywords

Acknowledgement

This study was conducted at Genomic Tree, Inc. during the SH Lee's sabbatical period of Yongin University. We thank staff members at Genomictree, Inc for their technical support.

References

  1. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 125:2995-3002. https://doi.org/10.1002/ijc.24745
  2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141-196. https://doi.org/10.1016/S0065-230X(08)60702-2
  3. Bhatlekar S, Fields, JZ, Boman BM (2018) Role of HOX genes in stem cell differentiation and cancer. Stem Cells Int 2018:3569493.
  4. Costello JF, Plass C (2001) Methylation matters. J Med Genet 38:285-303. https://doi.org/10.1136/jmg.38.5.285
  5. Cui Y, Gao D, Linghu E, Zhan Q, Chen R, Brock MV, Herman JG, Guo M (2015) Epigenetic changes and functional study of HOXA11 in human gastric cancer. Epigenomics 7:201-213. https://doi.org/10.2217/epi.14.92
  6. Dejeux E, EI abdalaoui H, Gut IG, Tost J (2009) Identification and quantification of differentially methylated loci by the pyrosequencing technology. Methods Mol Biol 507:189-205. https://doi.org/10.1007/978-1-59745-522-0_15
  7. Ehrlich M (2002) DNA methylation in cancer: Too much, but also too little. Oncogene 21:5400-5413. https://doi.org/10.1038/sj.onc.1205651
  8. Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, Widschwendter M (2008) HOXA11 DNA methylation-a novel prognostic biomarker in ovarian cancer. Int J Cancer 123:725-729. https://doi.org/10.1002/ijc.23563
  9. Glover HL, Schreiner A, Dewson G, Tait SWG (2024) Mitochondria and cell death. Nat Cell Biol (in press). doi: 10.1038/s41556-024-01429-4.
  10. He J, Li L, Wang S, Wu S, Xiao W, Li L, Dong L, Ge A, Xie K, Wang J (2024) Abnormal methylation of HOXA11 promoter promotes tumor progression in testicular germ cell tumor. Am J Transl Res 16:1660-1668. https://doi.org/10.62347/HJKI7733
  11. Kaplun DS, Kaluzhny DN, Prokhortchouk EB, Zhenilo SV (2022) DNA methylation: Genomewide distribution, regulatory mechanism and therapy target. Acta Naturae 14:4-19. https://doi.org/10.32607/actanaturae.11822
  12. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610. https://doi.org/10.1016/0092-8674(83)90092-2
  13. Li B, Huang Q, Wei GH (2019) The role of HOX transcription factors in cancer predisposition and progression. Cancers (Basel) 11:528.
  14. Li Q, Chen C, Ren X, Sun W (2017) DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma. Oncotarget 8:33100-33109. https://doi.org/10.18632/oncotarget.16528
  15. Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38:23-38. https://doi.org/10.1038/npp.2012.112
  16. Phillips T (2008) The role of methylation in gene expression. Nat Educ 1:116.
  17. Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528-537. https://doi.org/10.1016/S0008-6363(99)00384-3
  18. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S (2023) Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health 11:e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0
  19. Tai J, Wang G, Liu T, Wang L, Lin C, Li F (2012) Effects of siRNA targeting c-Myc and VEGF on human colorectal cancer Volo cells. J Biochem Mol Toxicol 26:499-505. https://doi.org/10.1002/jbt.21455
  20. Tait SW, Green DR (2010) Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621-632. https://doi.org/10.1038/nrm2952